What is myHIVteam?
Founded in 2011 and headquartered in San Francisco, California, myHIVteam operates a specialized online social networking platform designed to support individuals with various health conditions. The company's suite of platforms includes dedicated communities such as MyAutismTeam, MyBCTeam, MyMSTeam, and MyCrohnsandColitisTeam, among others. These platforms foster connection and provide resources for patients navigating chronic illnesses, positioning myHIVteam as a key player in the digital health and patient support sector.
How much funding has myHIVteam raised?
myHIVteam has raised a total of $27.2M across 6 funding rounds:
Angel/Seed
$1.8M
Series A
$3.4M
Series B
$5M
Series C
$7.3M
Other Financing Round
$9.4M
Debt
$350K
Angel/Seed (2012): $1.8M with participation from 500.com and Adams Street Partners
Series A (2014): $3.4M led by Adams Street Partners, Sand Hill Angels, The Westly Group, 500.com, HealthTechCapital, and TEEC
Series B (2015): $5M supported by Adams Street Partners, HealthTechCapital, Sand Hill Angels, CVS Health, and The Westly Group
Series C (2017): $7.3M featuring 500.com, CVS Health, HealthTech Capital, The Westly Group, Adams Street Partners, and Qiming Venture Partners
Other Financing Round (2019): $9.4M backed by UCB
Debt (2020): $350K with participation from PPP
Key Investors in myHIVteam
UCB
UCB is a global biopharmaceutical company focused on immunology and neurology, suggesting a strategic interest in patient support platforms that complement their therapeutic areas.
Adams Street Partners
Adams Street Partners, a firm specializing in private markets since 1972, has provided consistent backing, indicating a long-term investment strategy in growing companies.
CVS Health
CVS Health's investment highlights a strategic alignment with companies that enhance consumer health experiences and potentially integrate with broader healthcare delivery networks.
What's next for myHIVteam?
The recent major strategic investment in myHIVteam signals a pivotal stage for the company, likely enabling expansion of its platform offerings, enhancement of user engagement features, and broader market penetration. With a history of consistent capital raises, including Series A, B, and C rounds, the company is well-positioned to leverage this latest backing to further solidify its presence in the digital health community space. Future developments may include strategic partnerships and the integration of new health management tools.
See full myHIVteam company page
